Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

This article has a correction. Please see:

CORRECTION - September 01, 2008

Letter

Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome

Authors

A Salama PubMed articles Google scholar articles
U Schneider PubMed articles Google scholar articles
T Dörner PubMed articles Google scholar articles

Thomas Dörner, Charite Universitätsmedizin Berlin, Chariteplatz 1, 10098 Berlin, Germany; thomas.doerner{at}charite.de

Citation

Salama A, Schneider U, Dörner T

Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome

Annals of the Rheumatic Diseases 2008;67:894-895.

Publication history

Accepted September 17, 2007
First published May 12, 2008.

Online issue publication

June 30, 2016

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism